Thermography could offer a noninvasive way of assessing bleb function

Preoperative evaluation is not recommended for patients about to undergo cataract surgery – so why are ophthalmologists in the US continuing to order costly tests?

VR headsets could identify those with glaucoma at the greatest risk of falls

As many as six in every ten patients with glaucoma have ocular surface disease – and this can have a huge impact on their daily lives. We explore why, and what can be done.

Last year, we berated ourselves for the disappointing show of women in our Top 100 Power List (a measly 13 percent). So, how did we do in our Top 40 Under 40?

Managing dry eye disease becomes disproportionately more difficult as the severity of the disease increases: artificial tears and lubricants are not enough to help patients with severe dry eye disease.

Five Things We Learned This Month:

Sitting Down With… David Pyott, Chairman of the Board and Chief Executive Officer of Allergan, Inc.

The multifactorial nature of dry eye disease means that often, there’s a discordance between signs and symptoms, confounding diagnosis. Can things be improved?

We look at the last 50 years of Fight for Sight – the projects it has funded, and the discoveries its funding helped to achieve.